Anafarma SRL
The score of Anafarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +26 % Total assets +24 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Anafarma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 3,778 € | ||||
| Equity | 313,517 € | ||||
| Cash | 50,160 € | ||||
| EBITDA | 34,129 € | ||||
| Total assets | 474,117 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Anafarma's financial analysis
- Solvency66.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Anafarma
Anafarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0833.976.009
- VAT number
- BE0833976009
- Peppol
- Registered · 0208:0833976009 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Feb 2011
- Registered office
- 2221 Heist-op-den-Berg
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Anafarma (SRL) has been based in Heist-op-den-Berg since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 3,778 € and equity of 313,517 €; its revenue is not published. Its solvency stands at 66.1%, above the median of its sector (44.2%).
Companies similar to Anafarma
Companies in the same business, of comparable size and area, outside its group.
- MV Pharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 469,186 €
- Pharmacie Florair Retail sale of pharmaceutical products Jette · balance sheet 473,805 €
- L'Etoile Retail sale of pharmaceutical products Brussels · balance sheet 473,555 €
- Vereenooghe LDL Retail sale of pharmaceutical products Lendelede · balance sheet 377,699 €
- Apotheek Schockaert M. Retail sale of pharmaceutical products Dendermonde · balance sheet 473,175 €
- Hermelize Retail sale of pharmaceutical products Dilbeek · balance sheet 473,074 €
- Pharmalixhe Retail sale of pharmaceutical products Visé · balance sheet 476,967 €
- delta SUD PHARMA Retail sale of pharmaceutical products Virton · balance sheet 477,640 €
Frequently asked questions about Anafarma
What is the revenue of Anafarma?
Anafarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Anafarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0833976009 for Anafarma, if the company is VAT-registered. Its company number (CBE) is 0833.976.009.
Where is the registered office of Anafarma?
According to the CBE register, the registered office of Anafarma is in 2221 Heist-op-den-Berg.
What is the equity of Anafarma?
At the close of the 2025 financial year, the equity of Anafarma amounts to 313,517 €, a solvency of 66.1% of total assets.
Who manages Anafarma?
The register lists 2 active mandates at Anafarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Anafarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →